Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children With Seasonal Allergies

Study Title
Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Female, Maleergies
Teva Identifier
BDP-AR-305
ClinicalTrials.gov Identifier
NCT01307319
Study Status
Completed
Trial Condition(s)
Seasonal Female, Maleergic Rhinitis | SAR
Interventions
Drug: BDP HFA | Drug: Placebo nasal aerosol

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
6 Years to 11 Years
Trial Duration
03/01/2011 - 08/01/2011
Phase
Phase 3

Study Type

Interventional